Home

Applied Therapeutics, Inc. - Common Stock (APLT)

0.2587
-0.0220 (-7.84%)
NASDAQ · Last Trade: Nov 21st, 11:56 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.2807
Open0.2900
Bid0.2585
Ask0.2599
Day's Range0.2500 - 0.2900
52 Week Range0.2182 - 10.48
Volume9,341,047
Market Cap29.71M
PE Ratio (TTM)-2.587
EPS (TTM)-0.1
Dividend & YieldN/A (N/A)
1 Month Average Volume21,735,957

Chart

About Applied Therapeutics, Inc. - Common Stock (APLT)

Applied Therapeutics Inc. is a biotechnology company focused on developing innovative treatments for patients with serious and chronic diseases, particularly those with unmet medical needs. The company's research emphasizes the discovery and advancement of therapeutics that target underlying disease mechanisms, with a primary focus on conditions such as diabetic complications and other metabolic disorders. Applied Therapeutics aims to leverage its expertise in chemistry and biology to bring effective solutions to the market, enhancing patient outcomes and addressing critical health challenges. Through its dedication to scientific rigor and the development of novel compounds, the company strives to make a meaningful impact in the field of medicine. Read More

News & Press Releases

Applied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Optionsstocktwits.com
The board is considering mergers, acquisitions, partnerships, joint ventures, licensing arrangements or other strategic transactions, the company said.
Via Stocktwits · November 20, 2025
Applied Therapeutics Announces Corporate Updates
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that Applied Therapeutics’ Board of Directors (the “Board”) has initiated a process to explore strategic alternatives for the Company.
By Applied Therapeutics · Via GlobeNewswire · November 20, 2025
On Tuesday, there are stocks with unusual volume. Let's take a look.chartmill.com
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · November 18, 2025
What's going on in today's after hours sessionchartmill.com
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · November 17, 2025
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · November 17, 2025
These stocks are the most active in today's sessionchartmill.com
Monday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
Via Chartmill · November 17, 2025
Let's have a look at the top gainers and losers in the middle of the day of today's session.chartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Via Chartmill · November 17, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · November 17, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 17, 2025
Wondering what's happening in today's after-hours session?chartmill.com
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · November 14, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · November 14, 2025
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · November 13, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · November 13, 2025
Keep an eye on the top gainers and losers in Thursday's session.chartmill.com
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · November 13, 2025
Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertainbenzinga.com
Applied Therapeutics stock falls after FDA feedback prompts another Type C meeting to discuss the Phase 3 plan for its CMT-SORD drug govorestat.
Via Benzinga · November 13, 2025
Let's have a look at the top gainers and losers in the middle of the day of today's session.chartmill.com
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · November 13, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · November 13, 2025
Dow Dips Over 400 Points; JD.com Posts Upbeat Q3 Resultsbenzinga.com
Via Benzinga · November 13, 2025
Which stocks are gapping on Thursday?chartmill.com
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · November 13, 2025
Nasdaq Down Over 150 Points; Disney Shares Fall After Q4 Resultsbenzinga.com
Via Benzinga · November 13, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · November 13, 2025
Applied Therapeutics Reports Third Quarter 2025 Financial Results
–   Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes
By Applied Therapeutics · Via GlobeNewswire · November 13, 2025
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Applied Therapeutics, Inc. (NASDAQ: APLT) breached their fiduciary duties to shareholders.
By Halper Sadeh LLC · Via Business Wire · October 28, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · October 13, 2025
4 Biotech Stocks Seeing Explosive Momentum Gainsbenzinga.com
The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here's a look at several momentum standouts in the biotech space that appear to be rapidly gaining strength.
Via Benzinga · October 7, 2025